What does TARADON LABORATORY do?

TARADON LABORATORY is a commercial agency in Tubize. Public Limited, started on 19 November 2008, 1 establishment.

What is the address of TARADON LABORATORY?

The registered office of TARADON LABORATORY is located at Avenue Léon Champagne 2, 1480 Tubize.

Is TARADON LABORATORY still active?

Yes. According to the CBE (31 October 2026) TARADON LABORATORY is active, legal situation “Normale toestand”, started on 19 November 2008.

Is TARADON LABORATORY registered on Peppol?

Yes, TARADON LABORATORY is registered on the Peppol network with ID 0208:0807944078.

What is the enterprise number of TARADON LABORATORY?

The enterprise number of TARADON LABORATORY is BE0807944078.

When was TARADON LABORATORY founded?

TARADON LABORATORY was founded on 19 November 2008.

Who are the directors of TARADON LABORATORY?

According to the 2024 annual accounts, the directors of TARADON LABORATORY are: JEAN-BAPTISTE MOREL DE WEETGAVER, GIANCARLO BATTELLO, ANDRE CHAPELLE, Sophie DEDISSE.

Is TARADON LABORATORY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 November 2008; 4 annual accounts filed, latest fiscal year 2024; 4 directors known from the annual account.

How much profit did TARADON LABORATORY make in 2024?

TARADON LABORATORY recorded a loss after taxes of € 87,091 in financial year 2024.

What is the revenue of TARADON LABORATORY?

As a small company, TARADON LABORATORY is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € -50,341.

TARADON LABORATORY (Public Limited) - Tubize

Dossier TARADON LABORATORY, printed on 1 November 2026 from databakkes.be/en/0807944078/taradon-laboratory. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2023 and 2024.
Tight liquidity NBB

Cash and receivables cover 33 % of short-term debt in 2024; threshold 65 %.
Board fully replaced NBB

No director from three years ago is still active according to annual account 2024.
Busy address KBO

13 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2024

TARADON LABORATORY from Tubize, company number BE0807944078, closed financial year 2024 with a result of € -87,091 after tax. For that financial year TARADON LABORATORY recorded a gross margin of € -50,341 and equity of € -265,126. Compared with financial year 2023, the result moved from € -45,889 to € -87,091. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2025.

What it is worth Caution

€ -265,126

▲ € 2,909 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -87,091

▼ 90 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 22,348

▼ 15% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -326,626.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2024

Bank debt

€ 12,456

▼ 80% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 237,525

▼ 8% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,219

▼ 26% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ -289,388 Gross margin 2021: € -289,388 First fiscal year in the series	€ 251,407 Gross margin 2022: € 251,407 ▲ € 540,795 vs 2021 (€ -289,388) Favourable step	€ -9,009 Gross margin 2023: € -9,009 ▼ € 260,415 vs 2022 (€ 251,407) Unfavourable step	€ -50,341 Gross margin 2024: € -50,341 ▼ € 41,332 vs 2023 (€ -9,009) Unfavourable step	▼ € 41,332
Profit after taxes	€ -459,618 Profit after taxes 2021: € -459,618 First fiscal year in the series	€ 128,849 Profit after taxes 2022: € 128,849 ▲ € 588,467 vs 2021 (€ -459,618) Favourable step	€ -45,889 Profit after taxes 2023: € -45,889 ▼ € 174,738 vs 2022 (€ 128,849) Unfavourable step	€ -87,091 Profit after taxes 2024: € -87,091 ▼ € 41,203 vs 2023 (€ -45,889) Unfavourable step	▼ € 41,203
Equity	€ -350,995 Equity 2021: € -350,995 First fiscal year in the series	€ -222,146 Equity 2022: € -222,146 ▲ € 128,849 vs 2021 (€ -350,995) Favourable step	€ -268,035 Equity 2023: € -268,035 ▼ € 45,889 vs 2022 (€ -222,146) Unfavourable step	€ -265,126 Equity 2024: € -265,126 ▲ € 2,909 vs 2023 (€ -268,035) Favourable step	▲ € 2,909
Total debts	€ 1,323,506 Total debts 2021: € 1,323,506 First fiscal year in the series	€ 496,746 Total debts 2022: € 496,746 ▼ 62% vs 2021 (€ 1,323,506) Favourable step	€ 438,347 Total debts 2023: € 438,347 ▼ 12% vs 2022 (€ 496,746) Favourable step	€ 405,713 Total debts 2024: € 405,713 ▼ 7% vs 2023 (€ 438,347) Favourable step	▼ 7%
Cash	€ 2,587 Cash 2021: € 2,587 First fiscal year in the series	€ 53,314 Cash 2022: € 53,314 ▲ € 50,726 vs 2021 (€ 2,587) Favourable step	€ 26,395 Cash 2023: € 26,395 ▼ 50% vs 2022 (€ 53,314) Unfavourable step	€ 22,348 Cash 2024: € 22,348 ▼ 15% vs 2023 (€ 26,395) Unfavourable step	▼ 15%
Retained profit	€ -619,545 Retained profit 2021: € -619,545 First fiscal year in the series	€ -490,696 Retained profit 2022: € -490,696 ▲ € 128,849 vs 2021 (€ -619,545) Favourable step	€ -536,585 Retained profit 2023: € -536,585 ▼ € 45,889 vs 2022 (€ -490,696) Unfavourable step	€ -326,626 Retained profit 2024: € -326,626 ▲ € 209,959 vs 2023 (€ -536,585) Favourable step	▲ € 209,959
Bank debt	€ 100,104 Bank debt 2021: € 100,104 First fiscal year in the series	€ 100,000 Bank debt 2022: € 100,000 Unchanged (€ 100,104) Favourable step	€ 62,481 Bank debt 2023: € 62,481 ▼ 38% vs 2022 (€ 100,000) Favourable step	€ 12,456 Bank debt 2024: € 12,456 ▼ 80% vs 2023 (€ 62,481) Favourable step	▼ 80%
Balance sheet total	€ 972,511 Balance sheet total 2021: € 972,511 First fiscal year in the series	€ 274,600 Balance sheet total 2022: € 274,600 ▼ 72% vs 2021 (€ 972,511) Unchanged	€ 170,312 Balance sheet total 2023: € 170,312 ▼ 38% vs 2022 (€ 274,600) Unchanged	€ 140,587 Balance sheet total 2024: € 140,587 ▼ 17% vs 2023 (€ 170,312) Unchanged	▼ 17%

Key figures of TARADON LABORATORY, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to TARADON LABORATORY?

What happened at TARADON LABORATORY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2025 New annual accounts for financial year 2024: loss of € 87,091. Source: NBB ↗
2024 JEAN-BAPTISTE MOREL DE WEETGAVER became a director. NBB
2024 GIANCARLO BATTELLO stepped down as director. NBB
2024 ANDRE CHAPELLE stepped down as director. NBB
2024 Sophie DEDISSE stepped down as director. NBB
2022 Sophie DEDISSE became a director. NBB
2021 GIANCARLO BATTELLO became a director. NBB
2021 ANDRE CHAPELLE became a director. NBB

In short

From € 459,618 loss in 2021 to € 87,091 loss in 2024.

Paid € 19,823 in corporate taxes since 2021.

Best year ever: 2022, with € 128,849 profit.

Original PDFs at the National Bank ↗

Management

JEAN-BAPTISTE MOREL DE WEETGAVER

TARADON LABORATORY

TARADON PRODUCTION 100%

EUPHIA 0%

Behind TARADON LABORATORY is JEAN-BAPTISTE MOREL DE WEETGAVER. It owns 100% of TARADON PRODUCTION and 0% of EUPHIA itself.

Directors

According to the 2024 annual accounts

JEAN-BAPTISTE MOREL DE WEETGAVER

Managing director

since 2024

GIANCARLO BATTELLO

Director

Also active at: La Médicale de Noirchain

since 2021 · until 2024

ANDRE CHAPELLE

Director

since 2021 · until 2024

Sophie DEDISSE

Managing director

Also active at: TARADON PRODUCTION

since 2022 · until 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Léon Champagne 2

1480 Tubize

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.

All companies at this address →

PYRINDUS

€ 55,013 gross margin · 2025

D.C.

€ 177,523 gross margin · 2025

UNION DES ENTREPRISES POUR LE DEVELOPPEMENT DE L'OUEST DU BRABANT WALLON

SHANT LABORATORIES BELGIUM

€ 3,404 gross margin · 2025

L'AGE D'OR SERVICES BRABANT - OUEST

+8 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0807.944.078
VAT number: BE 0807.944.078
Registered office: Avenue Léon Champagne 2, 1480 Tubize
Names & denominations: TARADON LABORATORY
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 19 November 2008
Peppol: Active · Active since 31 Mar 2026
Activities · NACE: Handelsbemiddeling in de niet-gespecialiseerde groothandel

View on CBE Public ↗ Annual accounts (NBB) ↗